ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 135 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 2.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $7,631,000 | +99.2% | 232,874 | +51.8% | 0.26% | +88.3% |
| Q2 2016 | $3,831,000 | +75.3% | 153,443 | +130.0% | 0.14% | +73.4% |
| Q3 2015 | $2,186,000 | -49.3% | 66,716 | -18.0% | 0.08% | -47.0% |
| Q2 2015 | $4,312,000 | +53.3% | 81,407 | -16.4% | 0.15% | +53.6% |
| Q1 2015 | $2,812,000 | -2.2% | 97,426 | -1.4% | 0.10% | -16.4% |
| Q4 2014 | $2,875,000 | +136.8% | 98,830 | +3.2% | 0.12% | +152.2% |
| Q3 2014 | $1,214,000 | -38.2% | 95,722 | -2.1% | 0.05% | -28.1% |
| Q2 2014 | $1,963,000 | – | 97,809 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |